Atarax (Hydroxyzine) Is NOT Contraindicated in Bleeding Disorders
Hydroxyzine (Atarax) has no documented contraindications related to bleeding disorders. The FDA-approved prescribing information lists only two contraindications: early pregnancy (due to fetal abnormalities in animal studies) and previous hypersensitivity to the drug 1. There is no mention of bleeding disorders as a contraindication or precaution in the official drug labeling 1.
Key Points from FDA Labeling
The official Atarax prescribing information addresses:
- Contraindications: Early pregnancy and hypersensitivity only 1
- Precautions: CNS depression potentiation, drowsiness, and elderly patient considerations 1
- Adverse effects: Anticholinergic effects (dry mouth), CNS effects (drowsiness, rarely tremor/convulsions at high doses) 1
Notably absent: Any warnings, precautions, or contraindications related to coagulation, platelet function, or bleeding risk.
Clinical Context
The comprehensive 2025 British Journal of Anaesthesia guidelines on perioperative management of bleeding disorders 2 do not list hydroxyzine among medications requiring avoidance or dose adjustment in patients with hemophilia, von Willebrand disease, or other inherited bleeding disorders. The guidelines extensively detail medication considerations for these patients but make no reference to antihistamines as problematic agents.
Mechanism Considerations
Hydroxyzine is a first-generation H1-antihistamine with anticholinergic and sedative properties. Unlike NSAIDs (which inhibit platelet function) or anticoagulants (which affect clotting factors), hydroxyzine does not have known direct effects on:
- Platelet aggregation or function
- Coagulation cascade factors
- Fibrinolysis
- Vascular integrity
One older study from 1977 actually suggested hydroxyzine as part of premedication to block histamine-related complications during anesthesia 3, though this is not standard current practice.
Common Pitfall to Avoid
Do not confuse hydroxyzine with medications that DO affect hemostasis, such as:
- NSAIDs (platelet dysfunction)
- Anticoagulants (warfarin, DOACs)
- Antiplatelet agents (aspirin, clopidogrel)
- SSRIs (mild platelet dysfunction)
Bottom Line
Hydroxyzine can be safely prescribed to patients with bleeding disorders without dose adjustment or special precautions related to their hemostatic condition. Standard precautions regarding CNS depression and elderly patients apply regardless of bleeding disorder status 1.